The Bottom Line The appeal of needle-free GLP-1 options is understandable, but the current evidence does not support sublingual semaglutide drops or weight loss patches as effective alternatives to proven treatments
As with higher protein intakes, creatine is not appropriate for everyone, particularly those with impaired kidney function, and should only be used following a clinical assessment
You can also add electrolytes to help you with hydration at times when you feel dehydrated or if your urine looks dark yellow
Are pregnant or breastfeeding For a complete list of ingredients and safety details, refer to the Contrave medication guide
What Tirzepatide is studied for Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for glucose regulation, appetite signalling and metabolic research
Phase 2 trials (NEJM, 2023) reported mean resting heart rate increases of approximately 57 bpm at doses of 8 mg and 12 mg weekly